Autologous Cytokine-Induced Killer Cell Adoptive Immunotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome - Contacts and Locations

Autologous Cytokine-Induced Killer Cell Adoptive Immunotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome

This study is currently recruiting participants.

Study NCT00394381. Last updated on June 26, 2008. Information provided by Singapore General Hospital

Please refer to this study by its ClinicalTrials.gov identifier: NCT00394381

Contacts


Contact: Yeh-Ching Linn, MBBS, MRCP	(65) 62223322 ext 6608	linn.yeh.ching@sgh.com.sg

Contact: Mickey Koh, MBBS, MRCP, PhD	(65) 62130602	mickey_koh@hsa.gov.sg

Locations


Singapore
	Singapore General Hospital	Recruiting
	Singapore, Singapore, 169608
	Contact: Yeh-Ching Linn, MBBS, MRCP (65) 62223322 ext 6608 linn.yeh.ching@sgh.com.sg
	Contact: Mickey Koh, MBBS, MRCP, PhD (65) 62130602 Mickey_koh@hsa.gov.sg
	Sub-Investigator: Yeow Tee Goh, MBBS, M.Med
	Sub-Investigator: William Hwang, MBBS, MRCP, M Med

Sponsors and Collaborators

Singapore General Hospital

National Medical Research Council

Investigators


Principal Investigator:	Yeh-Ching Linn, MBBS, MRCP	Singapore General Hospital